RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

By June 4, 202515 views

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

S&P 500 Bullish Patterns: Are Higher Highs Ahead?

Top 5 Canadian Mining Stocks This Week: St. Augustine Rises 67 Percent on Private Placement

A new report released on Wednesday (June 11) by Canada’s Climate Institute suggests Canada risks ...

14Jun2025

Bold Ventures

Investor Insight A Canadian exploration company poised for discovery, Bold Ventures is focused on the ...

Leave a reply Cancel reply

Your email address will not be published. Required fields are marked *

Comment

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.

Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.